Comments
Commented by Juliane Zielonka on November 4th, 2022 | 11:21 CET
Aspermont, Apple, Amazon - Smart investments in stormy times
Tech shareholders are feeling the cold touch of the recession. But like a small Gallic village, Apple is defying the strong dollar. The Company sold 25% more Macs in the last quarter, even though PC sales declined worldwide. If you know exactly what your customers want, you can deliver exactly what they need. This motto is also used by the Canadian media company Aspermont. In the commodities scene, no insider can get past the now 30 media brands. Aspermont, in turn, uses its media platform to generate new data sets and treasures that benefit investors worldwide. Tech giant Amazon, on the other hand, is fishing in the waters of the competition with an enticing offer...
Read
Commented by Nico Popp on November 3rd, 2022 | 13:05 CET
Fear is spreading: Volkswagen, Varta, Altech Advanced Materials
Consulting firms like Roland Berger see the automotive industry undergoing a "triple transformation." No wonder large automotive groups are doing everything possible to become fit for the future. In addition to model electrification, digitization and greater sustainability are also playing a role in the battle for tomorrow's customers. Over the next three minutes, we explain what role technical innovations play in this.
Read
Commented by Fabian Lorenz on November 3rd, 2022 | 12:01 CET
BioNTech, Moderna and Defence Therapeutics right in the middle of the billion-dollar mRNA market! And Bayer?
BioNTech and Moderna's mRNA-based vaccines have successfully contributed to the containment of the COVID-19 pandemic. This has helped the relatively new technology for developing vaccines and other drugs to make a breakthrough. According to Precedence Research market researchers, the mRNA therapeutics market is expected to exceed USD 128 billion by 2030. The average annual growth would be around 13%. German top dog BioNTech is betting heavily on vaccines to fight cancer, among other things. Defence Therapeutics is now also entering the billion-dollar market, continuing the positive newsflow of recent weeks. The Canadians are opening up their platform for mRNA research, and their valuation is anything but expensive. Bayer is also too cheap at the moment. Analysts at least see a good 50% price potential.
Read
Commented by Stefan Feulner on November 3rd, 2022 | 11:53 CET
TeamViewer, Tocvan Ventures, Advanced Micro Devices - High rebound opportunities
The reporting season for the third quarter is exhilarating. It can be seen that stocks, which in some cases suffered exaggerated price losses in recent months, are starting to jump in price simply because their forecasts have been confirmed. Something similar could also happen in the precious metals sector. Should the monetary authorities loosen the monetary policy again in the coming months, this should result in a rally in gold and silver mining stocks.
Read
Commented by Juliane Zielonka on November 3rd, 2022 | 10:50 CET
Pathfinder Ventures, TUI, Meta - What is worth investing in now
The prices of tech stocks such as Meta, Alphabet and even Microsoft fall during periods of high-interest rates. The US Federal Reserve has strengthened the dollar, but exchange rate fees for internationally positioned companies are hurting profits. One complimentary to tech is the Canadian company Pathfinder Ventures. It operates state-of-the-art camping resorts in beautiful Canada and has seen a 47% increase in bookings for winter vacations. The 47% occupancy rate also represents a 9% increase over last year. Far from the buzzing server rooms and flickering office ceiling lights, families can relax in the great outdoors without sacrificing WiFi and other modern conveniences. Camping is the ideal alternative to package tour companies like TUI AG. The latter is currently cleaning up its board because the aftermath of the Corona pandemic is still ongoing.
Read
Commented by Armin Schulz on November 2nd, 2022 | 14:10 CET
BioNTech, XPhyto Therapeutics, MorphoSys - Biotech stocks facing a renaissance?
While the Corona pandemic plunged many companies into crisis, the biotech sector was the big winner. The fastest vaccine developers raked in record profits and are still profiting from vaccine orders today. Meanwhile, the Corona Crisis is no longer the focus of attention in many parts of the world. This is one of the reasons why the NASDAQ Biotech Index suffered significant losses until the end of September. In some cases, the shares of biotechnology companies were trading below their cash levels. Since October, things have been on the upswing. Reason enough to take a look at three interesting biotech companies.
Read
Commented by André Will-Laudien on November 2nd, 2022 | 13:34 CET
GreenTech shares jump! Siemens Energy, Defense Metals, JinkoSolar, and Nordex in focus
Fossil energy supply is becoming increasingly expensive. The political disappearance of supplier and commodity giant Russia is creating a dangerous undersupply, especially for Central Europe. The approaching winter could pose problems, and the industry might have to deal with rationing in the medium term. Products are becoming considerably more expensive to produce, and as a result, selling prices on the shelves are also increasing. The inflationary spiral is thus spiraling upward, and sales are falling. Meanwhile, GreenTech solutions are more in demand than ever for the purchase of energy. Which shares are playing to the fore here?
Read
Commented by Fabian Lorenz on November 2nd, 2022 | 12:34 CET
Gas price collapses: BASF, Porsche, Meta Materials in an upward trend
The sharp fall in gas prices is creating a good mood among investors. This week, the forward contract (TTF) for natural gas fell to below EUR 100 per MWh, its lowest level since June. This is fueling hopes that inflation will cool and the recession will be less severe. The direct beneficiary is, of course, BASF. In addition, a subsidiary is currently earning billions, and analysts see further price potential overall. According to them, the chemical group is currently "simply too cheap". This could also be the case with hot stock Meta Materials. Recently, new orders have given a boost to the share price. Should the Canadians continue the commercialization of the patent portfolio so successfully, significantly higher prices are possible. After the stuttering IPO, the Porsche share has stepped on the gas. But from the analysts' point of view, the air is slowly getting thinner.
Read
Commented by Nico Popp on November 2nd, 2022 | 11:29 CET
Castles in the Air to Cash Cows: Meta Platforms, Desert Gold, Varta
When Microsoft launched the first version of Windows decades ago, the Company was just one of many in the market for IT systems. When Apple introduced the iPhone, representatives of Nokia, among others, smiled at the novel phone without buttons. And today? Microsoft is the leader in PC operating systems, and phones without buttons are the absolute standard. We look at three stocks and analyze where today's castles in the air could become tomorrow's Cash Cows.
Read
Commented by Stefan Feulner on November 2nd, 2022 | 10:24 CET
BYD, Infinity Stone Ventures, Rock Tech Lithium - Profiteers of the energy transition
Electromobility plays a central role in achieving the ambitious goal of climate neutrality by 2050. Despite current production difficulties in the automotive industry due to the ongoing chip shortage, global supply chain problems and the effects of the war in Ukraine, demand for battery-powered vehicles continues unabated worldwide, as can be seen from the sales figures of electric car manufacturers. However, there is a problem here: the critical raw material lithium is already becoming scarce for the production of electric batteries. As a result, the already high prices are likely to rise further in the long term - to the advantage of the lithium producers.
Read